Transaction Details

Footnotes

The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025. | The shares of common stock were purchased by each of Empery Asset Master, LTD, Empery Tax Efficient, LP and Empery Tax Efficient III, LP (collectively the "Empery Purchasers") in in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025. | Empery Asset Management, LP (the "Investment Manager"), serves as the investment manager to each of the Empery Purchasers and certain other funds holding shares of the Issuer's common stock (collectively, the "Empery Funds"). The Reporting Person is a Managing Member of Empery AM GP, LLC (the "General Partner"), the general partner of the Investment Manager. The Investment Manager may be deemed to be the beneficial owner of all of the common stock held by the Empery Funds. The Reporting Person, as Managing Member of the General Partner of the Investment Manager with the power to exercise investment discretion, may be deemed to be the beneficial owner of all of the common stock held by the Empery Funds. The Reporting Person is the Issuer's Co-Chief Executive Officer and Chairman of its board of directors. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. | The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan. | The stock options were issued by the Issuer in connection with the Reporting Person's employment service as Co-Chief Executive Officer and chairman of the board of directors of the Issuer on July 17, 2025. All vesting is subject to the approval by the Issuer's stockholders of a new stock option plan.